Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The COVID-19 pandemic has had a disproportionate and devastating impact on women’s health, according to a report from the Royal College of Obstetricians and Gynaecologists.

Copyright: Shutterstock

The report found that more than half a million women in the UK have been forced to wait for “non-urgent” gynaecological care. Waiting lists across the country are now 60% longer than pre-pandemic levels. This means that one in 20 women will now be waiting more than a year to receive gynaecological surgery, specialist treatments and even diagnoses.

Some of those hardest hit by these delays are women suffering with endometriosis, the chronic inflammatory condition characterised by tissue similar to the womb lining growing elsewhere in the body – in places such as the ovaries or fallopian tubes. An estimated one in ten women have the condition, many of which live with excruciating pain.

If left untreated or poorly managed, the condition can worsen. This can make it far more challenging to treat, and may have a long-lasting impact on the woman’s health – such as causing fertility problems or worsened pain.

Read the full article (written by Danielle Perro and Prof Christian Becker) in The Conversation here. 

Similar stories

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New imaging study could make diagnosing endometriosis quicker, more accurate and reduce the need for invasive surgery.

A new research study launches to investigate whether a 20-minute imaging scan can detect the most common types of endometriosis, which currently require surgery to diagnose.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Diagnostic test could offer new hope for ME/CFS patients

Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.

MitOX 2022- 8th April

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2022 on Friday 8th April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!

New guidelines launched for diagnosis and management of Endometriosis

A new comprehensive document by the European Society of Human Reproduction and Embryology (ESHRE) outlines more than 100 recommendations on best practice on caring for women with Endometriosis.